ImmunityBio, Inc.
IBRXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $8.63B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.95$12.43
- Volume (live)
- -
- Avg. volume (3M)
- 14.98M
ImmunityBio (IBRX) Stock Price & Financial Analysis
ImmunityBio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.05 - $8.36 |
|---|---|
| 52-Week High | $12.43 |
| 52-Week Low | $1.95 |
| Open | $8.21 |
| Volume (last close) | 5.94M |
| Average Volume (3M) | 14.98M |
| Revenue (TTM) | 165.79M |
|---|---|
| Net Income (TTM) | -992.36M |
| Free Cash Flow (TTM) | -288.48M |
| EPS (TTM) | −$0.99 |
| Profit Margin | -598.56% |
| Operating Margin | -151.88% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 8.63B |
|---|---|
| Shares Outstanding | 1.05B |
| Price to Sales (P/S) | 52.06 |
| Price to Book (P/B) | -8.25 |
| EV/EBITDA | -13.07 |
| 50-Day MA | $8.60 |
|---|---|
| 200-Day MA | $7.66 |
| 1-Year Change | +247.70% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
ImmunityBio at a Glance
As of the Oct 23, 2026 close, ImmunityBio (IBRX) has a market capitalization of $8.63B. The stock trades at 52.1× sales. Over the trailing twelve months it lost $992.36M on revenue of $165.79M and burned $288.48M of free cash flow. Revenue grew 192.9% year over year.
As of its latest reported balance sheet, it holds $75.67M in cash and securities against $813.06M of debt, a net debt position of $737.39M.
ImmunityBio does not currently pay a dividend.
The share price is up 247.7% over the past year. At $8.22 (the Oct 23, 2026 close) it sits within its 52-week range of $1.95 to $12.43, above its 200-day moving average of $7.66.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About ImmunityBio
What is the current stock price for IBRX?
As of the Oct 23, 2026 close, IBRX stock trades at $8.22. The 52-week range is $1.95–$12.43, with a day range of $8.05–$8.36.
What is the P/E ratio for IBRX?
The P/E ratio (Price-to-Earnings) for IBRX is shown in the Key Statistics section. This valuation metric helps compare ImmunityBio, Inc. to industry peers.
Does IBRX pay dividends?
ImmunityBio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IBRX?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for IBRX is Hold.
What is the market cap of IBRX?
As of the Oct 23, 2026 close, ImmunityBio's market capitalization is $8.63B, classifying it as a mid-cap company. ImmunityBio operates in the Healthcare sector within the Biotechnology industry.